Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Items 101–200 of 859
Intersection of AHR and Wnt Signaling in Development, Health, and Disease
Schneider, A., Branam, A., & Peterson, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017852 · Cited by 106
“Overactive canonical Wnt signaling can lead to tumor development in the intestines [23,125], which could explain why Ahr−/− mice spontaneously develop tumors in the cecum.”
BackgroundCan Stopping Nerves, Stop Cancer?
Saloman, J. L., Albers, K. M., Rhim, A. D., & Davis, B. M. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.002 · Cited by 115
“In the gastric cancer model, linkage is suggested between a down-regulation of WNT signaling, a pathway invoked in multiple cancers [72-74] and the expression of type 3 muscarinic receptors in a subset of gastric epithelial cells that express the Lrg5 G-proteincoupled receptor.”
Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways
Wang, W., Dong, X., Liu, Y., Ni, B., Sai, N., You, L., Sun, M., Yao, Y., Qu, C., Yin, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110661 · Cited by 105
Kumar, P., & Mistri, T. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.016 · Cited by 108
Wnt Signalling in Gastrointestinal Epithelial Stem Cells
Flanagan, D. J., Austin, C. R., Vincan, E., & Phesse, T. J. (2018) · Genes · doi:10.3390/genes9040178 · Cited by 120
“Collectively, these studies depict a challenging obstacle to successfully treat CRC given the plasticity of differentiated cells to acquire stem cell properties.”
BackgroundInfluentialBroad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
Bizzarri, M., Dinicola, S., Bevilacqua, A., & Cucina, A. (2016) · International Journal of Endocrinology · doi:10.1155/2016/5616807 · Cited by 115
“Indeed, InsP6 has been already shown to inhibit the IGF-1 receptor pathway-mediated sustained growth in cancer cells [85].”
BackgroundInfluentialWang, G., Li, R., Parseh, B., & Du, G. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118192 · Cited by 108
Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling
Mariotti, L., Templeton, C. M., Ranes, M., Paracuellos, P., Cronin, N., Beuron, F., Morris, E., & Guettler, S. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.019 · Cited by 98
“Wnt-b-catenin signaling, which is dysregulated in most colorectal cancers, provides prominent examples for signalosomes (Bienz, 2014; Polakis, 2012).”
BackgroundMolecular regulation and pharmacological targeting of the β‐catenin destruction complex
van Kappel, E. C., & Maurice, M. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13922 · Cited by 106
Wnt Signaling in the Central Nervous System: New Insights in Health and Disease
Oliva, C. A., Montecinos-Oliva, C., & Inestrosa, N. C. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.018 · Cited by 110
Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs
Mao, L., Li, J., Chen, W., Cai, Y.-Q., Yu, D., Zhong, S., Zhao, J., Zhou, J., & Tang, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4402-2 · Cited by 104
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yan, Y., Zeng, J., Xing, L., & Li, C. (2021) · Biomedicines · doi:10.3390/biomedicines9081014 · Cited by 96
“The Wnt pathway is commonly divided into β-catenin dependent (canonical) and independent (non-canonical) signaling [90].”
BackgroundNeurodevelopmental Perspectives on Wnt Signaling in Psychiatry
Mulligan, K. A., & Cheyette, B. N. R. (2016) · Complex Psychiatry · doi:10.1159/000453266 · Cited by 95
Long Non-Coding RNA and Breast Cancer
Zhang, T., Hu, H., Ge, Y., Wu, T., Liu, S., Chen, W., Ning, Y., & Lu, Z. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819843889 · Cited by 103
FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma
Walker, M. P., Stopford, C. M., Cederlund, M., Fang, F., Jahn, C., Rabinowitz, A. D., Goldfarb, D., Graham, D. M., Yan, F., Deal, A. M., et al. (2015) · Science Signaling · doi:10.1126/scisignal.2005654 · Cited by 94
“www pathway activity is a hallmark of several human cancers, including colon and liver cancer, in which mutations in core signaling components result in constitutive pathway activity and oncogenesis (4, 5).”
BackgroundWnt target genes and where to find them
Ramakrishnan, A., & Cadigan, K. M. (2017) · F1000Research · doi:10.12688/f1000research.11034.1 · Cited by 103
Fatty acylation of Wnt proteins
Nile, A. H., & Hannoush, R. N. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2005 · Cited by 95
TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling
Jung, Y.-S., Jun, S., Kim, M. J., Lee, S. H., Suh, H. N., Lien, E. M., Jung, H.-Y., Lee, S., Zhang, J., Yang, J.-I., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0219-8 · Cited by 93
Multifaceted roles of Adiponectin in cancer
Hebbard, L., & Ranscht, B. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.005 · Cited by 103
Zhang, M., Miao, F., Huang, R. S., Liu, W., Zhao, Y., Jiao, T., Lu, Y., Wu, F., Wang, X., Wang, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0687-5 · Cited by 101
“GSK3β and CK1 phosphorylate ser/thr 33/37/41/45 on β-catenin, which leads to its degradation by the proteasome [30].”
BackgroundCaspi, M., Wittenstein, A., Kazelnik, M., Shor-Nareznoy, Y., & Rosin‐Arbesfeld, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.010 · Cited by 96
Signaling Pathways in Cell Polarity
McCaffrey, L. M., & Macara, I. G. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009654 · Cited by 90
Frizzled7: A Promising Achilles’ Heel for Targeting the Wnt Receptor Complex to Treat Cancer
Phesse, T. J., Flanagan, D. J., & Vincan, E. (2016) · Cancers · doi:10.3390/cancers8050050 · Cited by 98
“For example, it is now established that Apc is mutated in 80%–90% of colorectal tumours [73].”
BackgroundRole of microRNAs in the main molecular pathways of hepatocellular carcinoma
Vasuri, F., Visani, M., Acquaviva, G., Brand, T., Fiorentino, M., Pession, A., Tallini, G., D’Errico, A., & de Biase, D. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i25.2647 · Cited by 93
Primary cilia and their role in cancer (Review)
Higgins, M. J., Obaidi, I., & McMorrow, T. (2019) · Oncology Letters · doi:10.3892/ol.2019.9942 · Cited by 124
“Adenomatous polyposis coli is a tumor suppressor, which is significantly associated with Wnt signaling, and it has been demonstrated to be implicated in β-catenin regulation (57).”
BackgroundWnt2 complements Wnt/β-catenin signaling in colorectal cancer
Jung, Y.-S., Jun, S., Lee, S. H., Sharma, A., & Park, J.-I. (2015) · Oncotarget · doi:10.18632/oncotarget.6133 · Cited by 88
“For example, more than 70 % of CRC cells display somatic mutation in Wnt signaling components including APC, β-catenin/CTNNB1, or AXIN1 [4, 5].”
BackgroundThe roles and mechanisms of YTH domain-containing proteins in cancer development and progression.
Liu, S., Li, G., Li, Q., Zhang, Q., Zhuo, L., Chen, X., Zhai, B., Sui, X., Chen, K., & Xie, T. (2020) · PubMed · Cited by 99
Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance
Nelson, S., & Näthke, I. S. (2013) · Journal of Cell Science · doi:10.1242/jcs.100479 · Cited by 86
“The loss of this particular function of APC has a major role in tumorigenesis, as the resulting increased availability of bcatenin causes changes in transcriptional programmes to decrease the amount of cell differentiation (Polakis, 2012).”
BackgroundMASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
Uppada, S. B., Gowrikumar, S., Ahmad, R., Kumar, B., Szeglin, B., Chen, X., Smith, J. J., Batra, S. K., Singh, A. B., & Dhawan, P. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0848-3 · Cited by 85
Shetti, D., Zhang, B., Fan, C., Mo, C., Lee, B. H., & Wei, K. (2019) · Cells · doi:10.3390/cells8080892 · Cited by 85
“Wnt signaling is an essential cellular process associated with cell fate (development, differentiation, and proliferation), but it is inappropriately regulated in multiple types of cancer [7,8].”
BackgroundDevelopment of anticancer agents targeting the Wnt/β-catenin signaling.
Zhang, X., & Hao, J. (2015) · Europe PMC (PubMed Central) · Cited by 107
The role of RNA alternative splicing in regulating cancer metabolism
Kozlovski, I., Siegfried, Z., Amar-Schwartz, A., & Karni, R. (2017) · Human Genetics · doi:10.1007/s00439-017-1803-x · Cited by 98
Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 93
Targeting nuclear import and export in hematological malignancies
Nachmias, B., & Schimmer, A. D. (2020) · Leukemia · doi:10.1038/s41375-020-0958-y · Cited by 89
“Wnt signal transduction culminates in the IPOβ1-mediated nuclear import of βcatenin [86].”
BackgroundWang, S.-H., Chang, J. S.-M., Hsiao, J. R., Yen, Y.-C., Jiang, S. S., Liu, S.-H., Chen, Y.-L., Shen, Y.-Y., Chang, J.-Y., & Chen, Y.-W. (2016) · Oncogene · doi:10.1038/onc.2016.317 · Cited by 90
The ubiquitin-like modifier FAT10 in cancer development
Aichem, A., & Groettrup, M. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.001 · Cited by 89
Roles of the Wnt Signaling Pathway in Head and Neck Squamous Cell Carcinoma
Xie, J., Huang, L., Lu, Y., & Zheng, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.590912 · Cited by 90
“…cell carcinoma Promote growth and survival, inhibit apoptosis Shiah et al., 2014 Wnt11 Non-canonical – Oral squamous cell carcinoma Suppress tumor Andrade Filho et al., 2011 intracellular conduction medium, are often disrupted by genetic or epigenetic inheritance in human tumors (Polakis, 2012).”
BackgroundTewari, D., Bawari, S., Sharma, S., DeLiberto, L. K., & Bishayee, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107876 · Cited by 88
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells
Nile, A. H., Melo, F. D. S. E., Mukund, S., Piskol, R., Hansen, S., Zhou, L., Zhang, Y., Fu, Y., Gogol, E. B., Kömüves, L. G., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0035-2 · Cited by 90
Chromatin-Remodeling-Factor ARID1B Represses Wnt/β-Catenin Signaling
Vasileiou, G., Ekici, A. B., Uebe, S., Zweier, C., Hoyer, J., Engels, H., Behrens, J., Reis, A., & Hadjihannas, M. V. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.08.002 · Cited by 81
“In the presence of Wnt ligands, this destruction complex is inactivated and b-catenin is stabilized and subsequently translocates to the nucleus to activate transcription of Wnt target genes.(20) Wnt target genes control a variety of cellular processes, including proliferation, differentiation, and pluripotency.”
BackgroundSorcin a Potential Molecular Target for Cancer Therapy
Shabnam, B., Padmavathi, G., Banik, K., Girisa, S., Monisha, J., Sethi, G., Fan, L., Wang, L., Mao, X., & Kunnumakkara, A. B. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.08.015 · Cited by 80
Xu, P., Ianes, C., Gärtner, F., Liu, C., Burster, T., Bakulev, V. A., Rachidi, N., Knippschild, U., & Bischof, J. (2019) · Gene · doi:10.1016/j.gene.2019.144005 · Cited by 87
“In many types of cancers alterations or mutations in the Wnt pathway have been observed (Clevers and Nusse, 2012; Polakis, 2012; Nusse and Clevers, 2017; Krishnamurthy and Kurzrock, 2018).”
BackgroundToward an integrated map of genetic interactions in cancer cells
Rauscher, B., Heigwer, F., Henkel, L., Hielscher, T., Voloshanenko, O., & Boutros, M. (2018) · Molecular Systems Biology · doi:10.15252/msb.20177656 · Cited by 80
“Both, APC and RNF43 , are frequently mutated negative regulators of the Wnt/ b -catenin signaling pathway (Polakis, 2012; de Lau et al , 2014; Tsukiyama et al , 2015; Zhan et al , 2017) — a pathway that is aberrantly regulated in various cancers (Polakis, 2012; Giannakis et al , 2014; Zhan et al ,…”
Guernet, A. A., Mungamuri, S. K., Cartier, D., Sachidanandam, R., Jayaprakash, A. D., Adriouch, S., Vézain, M., Charbonnier, F., Rohkin, G., Coutant, S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.017 · Cited by 89
“The APC tumor suppressor gene encodes a major component of the destruction complex that promotes the degradation of free b-catenin, and it is mutated in more than 80% of colorectal cancers (Clevers and Nusse, 2012; Polakis, 2012).”
BackgroundKhurana, N., & Sikka, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092066 · Cited by 86
Targeting Wnt Signaling in Endometrial Cancer
Fatima, I., Barman, S., Rai, R., Thiel, K. W., & Chandra, V. (2021) · Cancers · doi:10.3390/cancers13102351 · Cited by 85
Liang, G., Liu, M., Wang, Q., Shen, Y., Mei, H., Li, D., & Liu, W. (2017) · Oncotarget · doi:10.18632/oncotarget.15324 · Cited by 78
“This correlation was also observed in the pathogenesis of malignant melanoma [42, 43].”
Chen, W., Zhao, W., Zhang, L., Wang, L., Wang, J., Wan, Z., Hong, Y., & Yu, L. (2017) · Oncotarget · doi:10.18632/oncotarget.21693 · Cited by 78
Therapeutic targeting of casein kinase 1δ in breast cancer
Rosenberg, L. H., Lafitte, M., Quereda, V., Grant, W. M., Chen, W., Bibian, M., Noguchi, Y., Fallahi, M., Yang, C., Chang, J. C., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac8773 · Cited by 78
“) regulatory components of the Wnt pathway are prevalent at a high frequency in human cancers [reviewed by (34)].”
BackgroundDerlindati, E., Dei Cas, A., Montanini, B., Spigoni, V., Curella, V., Aldigeri, R., Ardigò, D., Zavaroni, I., & Bonadonna, R. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119751 · Cited by 77
“Wnt proteins, through the canonical and non canonical transduction pathways are involved in inflammatory processes [48] such as atherosclerosis, as well as in regulating cell proliferation and differentiation [49] and in cancer development [50].”
BackgroundLecarpentier, Y., CLAES, V. A., Vallée, A., & Hébert, J. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0144-7 · Cited by 80
“of PPAR gamma in cancers WNT/beta-catenin signaling has been found to be activated in cancers [92, 93].”
BackgroundProgress and challenges of sequencing and analyzing circulating tumor cells
Zhu, Z., Qiu, S., Shao, K., & Hou, Y. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9418-5 · Cited by 78
“Previous studies have highlighted particular molecular pathways involved with cancer metastasis, such as TGF-β signaling (Akhurst and Derynck 2001), Wnt signaling (Polakis 2012), and EMT (Gonzalez and Medici 2014).”
BackgroundWang, Z., Yang, M., Lei, L., Fei, L., Zheng, Y.-W., Huang, W., Li, Z., Liu, C., & Xu, H. (2019) · Cancer Management and Research · doi:10.2147/cmar.s218926 · Cited by 91
“Activation of the Wnt pathway leads to malignant transformation, and eventually tumor formation.(32) To date, there have been no reports regarding KRT17 involvement in theWnt signaling pathway.”
BackgroundSantoyo-Ramos, P., Likhatcheva, M., García-Zepeda, E. A., Castañeda-Patlán, M. C., & Robles-Flores, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112580 · Cited by 75
“Indeed, a great amount of experimental evidence has shown that mutations in the adenomatous polyposis coli (APC) gene act as gatekeepers in the molecular pathogenesis of the majority of sporadic and hereditary forms of colorectal carcinoma [1,2].”
Gao, Y., Liu, Z., Zhang, X., He, J., Pan, Y., Hao, F., Xie, L., Li, Q., Qiu, X., & Wang, E. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.005 · Cited by 80
“A complex of b-catenin and TCF/LEF activates Wnt target genes, such as cyclin D1, c-myc, matrix metal-proteinase-7 (MMP-7) and CD44 [19,20] as well as survivin, which is upregulated in most human tumors to promote survival [21].”
Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention
Shin, W. J., Zabel, B. A., & Pachynski, R. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02772 · Cited by 75
“Aberrant activation of the Wnt/β-catenin pathway is common in many other cancer types, such as breast cancer, lung cancer, hepatocellular carcinoma, and squamous cell carcinoma (47).”
BackgroundAberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
Bongiovanni, D., Saccomani, V., & Piovan, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091904 · Cited by 84
“Wnt signaling plays an important role in normal hematopoiesis [229,230], and it often becomes de-regulated in malignancies of the hematological system [231].”
BackgroundTherapeutic Inducers of Apoptosis in Ovarian Cancer
Binju, M., Amaya-Padilla, M. A., Wan, G., Gunosewoyo, H., Rahmanto, Y. S., & Yu, Y. (2019) · Cancers · doi:10.3390/cancers11111786 · Cited by 82
Yi, J. J., Paranjape, S. R., Walker, M. P., Choudhury, R., Wolter, J. M., Fragola, G., Emanuele, M. J., Major, M. B., & Zylka, M. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.788448 · Cited by 80
“Abnormal Wnt signaling is implicated in autism pathogenesis (14 –17), and Wnt signaling is dysregulated in other diseases, including cancer (18, 19).”
BackgroundBeta-Catenin Causes Adrenal Hyperplasia by Blocking Zonal Transdifferentiation
Pignatti, E., Leng, S., Yuchi, Y., Borges, K. S., Guagliardo, N. A., Shah, M. S., Ruiz‐Babot, G., Kariyawasam, D., Taketo, M. M., Miao, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107524 · Cited by 85
“…or loss-of-function (LOF) mutations in key negative regulators, such as APC (adenomatous polyposis coli) or in the transmembrane E3 ubiquitin ligase ZNRF3 (zinc and ring finger 3), leads to tissue hyperplasia and ultimately to neoplastic transformation (Nusse and Clevers, 2017; Polakis, 2012).”
Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis
Koelwyn, G. J., Aboumsallem, J. P., Moore, K. J., & de Boer, R. A. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.09.008 · Cited by 74
“development of CVD by mediating hypertrophy, fibrosis, and ischemia [53], as well as malignant transformation and cancer cell proliferation in many cancer types [54].”
BackgroundYun, J., Hansen, S., Morris, O., Madden, D. T., Libeu, C. P., Kumar, A. J., Wehrfritz, C., Nile, A. H., Zhang, Y., Zhou, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35487-9 · Cited by 88
WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma
Long, A., Giroux, V., Whelan, K. A., Hamilton, K. E., Tétreault, M.-P., Tanaka, K., Lee, J., Klein–Szanto, A. J., Nakagawa, H., & Rustgi, A. K. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv025 · Cited by 77
Wnt signaling in castration-resistant prostate cancer: implications for therapy.
Yokoyama, N. N., Shao, S., Hoang, B. H., Mercola, D., & Zi, X. (2014) · PubMed · Cited by 75
Sasidharan Nair, V., Saleh, R., Toor, S. M., Taha, R. Z., Ahmed, A. A., Kurer, M. A., Murshed, K., Alajez, N. M., Abu Nada, M., & Elkord, E. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0808-9 · Cited by 72
Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment
Pandey, M. K., Gupta, S. C., Nabavizadeh, A., & Aggarwal, B. B. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.002 · Cited by 76
“canonical (β-catenin independent) [87, 88].”
miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer
Liu, S., Wang, Z., Liu, Z., Shi, S., Zhang, Z., Zhang, J., & Lin, H. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy041 · Cited by 80
Tůmová, L., Pombinho, A. R., Vojtěchová, M., Stančíková, J., Gradl, D., Krausová, M., Šloncová, E., Horázná, M., Kříž, V., Machoňová, O., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0625 · Cited by 75
Chen, B., Wang, J., Dai, D., Zhou, Q. S., Guo, X., Tian, Z., Huang, X., Yang, L., Tang, H., & Xie, X. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0522-4 · Cited by 80
Oncogenic signalling pathways in benign odontogenic cysts and tumours
Diniz, M. G., Gomes, C. C., de Sousa, S. F., Xavier, G. M., & Gomez, R. S. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.07.021 · Cited by 74
“associated with the pathogenesis of several types of cancer [99] and odontogenic lesions, especially COC.”
BackgroundLncRNA as a multifunctional regulator in cancer multi-drug resistance
He, J., Zhu, S., Liang, X., Zhang, Q., Luo, X., Liu, C., & Song, L. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06603-7 · Cited by 75
Yang, C., Du, W., & Yang, D. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1198892 · Cited by 69
“Activation of Wnt/b-catenin signalling contributes to carcinogenesis in a subset of cancers (OchoaHernandez et al. 2012; Polakis 2012; Sherwood 2015).”
BackgroundProtein Phosphatase 2A in the Regulation of Wnt Signaling, Stem Cells, and Cancer
Thompson, J. J., & Williams, C. S. (2018) · Genes · doi:10.3390/genes9030121 · Cited by 81
“Wnt sig ali g is known to regulate patternin and cell fat decisions during embryonic development, nd has bee implicated in the pa hogenesis of cancer [9].”
BackgroundZhu, G.-X., Gao, D., Shao, Z., Chen, L., Ding, W., & Yu, Q. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11744 · Cited by 78
Tran, H., Bustos, D. J., Yeh, R., Rubinfeld, B., Lam, C., Shriver, S. K., Zilberleyb, I., Lee, M. W., Phu, L., Sarkar, A. A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415240 · Cited by 63
“Aberrant activation ofWnt signaling is also linked to a variety of human cancers (2).”
BackgroundSelf-citationThe Role of Wnt Signaling in Squamous Cell Carcinoma
Shiah, S., Shieh, Y., & Chang, J. (2015) · Journal of Dental Research · doi:10.1177/0022034515613507 · Cited by 71
Fang, Z., Cao, B., Liao, J., Deng, J., Plummer, K. D., Liao, P., Liu, T., Zhang, W., Zhang, K., Li, L., et al. (2018) · eLife · doi:10.7554/elife.31275 · Cited by 70
“First, SPIN1 has been reported to execute its oncogenic potentials by activating Wnt and PI3K/Akt pathways (Chen et al., 2016; Wang et al., 2012), both of which are closely correlated with cancer progression (Liu et al., 2009; Polakis, 2012).”
Competitive Binding of a Benzimidazole to the Histone-Binding Pocket of the Pygo PHD Finger
Miller, T. C. R., Rutherford, T. J., Birchall, K., Chugh, J., Fiedler, M., & Bienz, M. (2014) · ACS Chemical Biology · doi:10.1021/cb500585s · Cited by 67
Zhao, Y., Yi, J., Tao, L., Huang, G., Chu, X., Song, H., & Chen, L. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0466-4 · Cited by 67
Competitive cell interactions in cancer: a cellular tug of war
Wagstaff, L., Kolahgar, G., & Piddini, E. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.11.002 · Cited by 77
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00352 · Cited by 68
“GAMMA IN GLIOMAS WNT/beta-catenin signaling has been activated in cancers (Polakis, 2012a,b).”
BackgroundSui, Q., Liu, D., Jiang, W., Tang, J., Kong, L., Han, K., Liao, L., Li, Y., Ou, Q., Xiao, B., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001498 · Cited by 66
Organoids and Colorectal Cancer
Barbáchano, A., Fernández‐Barral, A., Bustamante‐Madrid, P., Prieto, I., Rodríguez-Salas, N., Larriba, M. J., & Múñoz, A. (2021) · Cancers · doi:10.3390/cancers13112657 · Cited by 81
“Organoids have been extensively used to study the WNT/β-catenin pathway, which is essential for normal SC homeostasis at the intestinal crypt bottom and crucial for CRC initiation and progression when deregulated [5,22,68,69].”
BackgroundJamieson, C., Lui, C., Brocardo, M. G., Martino‐Echarri, E., & Henderson, B. R. (2015) · Journal of Cell Science · doi:10.1242/jcs.167742 · Cited by 75
“Our model offers a novel role for active Rac1 in modulating the Wnt signaling pathway and provides an alternative explanation for the often-reported links between Rac1 expression and Wnt in relation to colorectal cancer (Fritz et al., 1999; Gómez del Pulgar et al., 2005; Polakis, 2012) and colorectal carcinoma cell li…”
Diet-Derived Phytochemicals Targeting Colon Cancer Stem Cells and Microbiota in Colorectal Cancer
Ganesan, K., Jayachandran, M., & Xu, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113976 · Cited by 70
“Conversely, the loss of function of adenomatous polyposis coli or gain of function of β-catenin causes the balance of unrestricted β-catenin that provides abnormal Wnt signaling leads to tumorigenesis [161].”
BackgroundShaping functional gut microbiota using dietary bioactives to reduce colon cancer risk
Seidel, D., Azcárate-Peril, M. A., Chapkin, R. S., & Turner, N. D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.009 · Cited by 69
Massey, J., Liu, Y., Alvarenga, O. E., Saez, T., Schmerer, M. W., & Warmflash, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815363116 · Cited by 70
“Mutations in WNT/β-catenin pathway components are frequently found in human cancers (5, 6).”
BackgroundYen, H., Tsao, C., Lin, Y., Kuo, C.-C., Tsao, C., & Liu, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53509-3 · Cited by 72
Expression of the stem cell marker, SOX 2, in ameloblastoma and dental epithelium
Juuri, E., Isaksson, S., Jussila, M., Heikinheimo, K., & Thesleff, I. (2013) · European Journal Of Oral Sciences · doi:10.1111/eos.12095 · Cited by 64
Zong, Z., Song, Y., Xue, Y., Ruan, X., Liu, X., Yang, C., Zheng, J., Cao, S., Li, Z., & Liu, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14362 · Cited by 67
Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma
Liu, Y., Chen, H., Sun, Z., & Chen, X. L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.006 · Cited by 71
“chemical inhibition of γ-secretase or expression of a Notch1 mutant inhibits Wnt signaling [175,176].”
BackgroundHong, C.-S., Jeong, O., Piao, Z., Chen, G., Jung, M.-R., Choi, C., & Park, Y. (2015) · Biochemical Journal · doi:10.1042/bj20150213 · Cited by 68
Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus
Pai, P., Rachagani, S., Dhawan, P., & Batra, S. K. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw005 · Cited by 66
The cilia-regulated proteasome and its role in the development of ciliopathies and cancer
Gerhardt, C., Leu, T., Lier, J. M., & Rüther, U. (2016) · Cilia · doi:10.1186/s13630-016-0035-3 · Cited by 63
“In some tumors, this kind of phosphorylation is prevented by mutations resulting in a stabilization of β-catenin which then is able to activate the transcription of many oncogenes [73, 74].”
BackgroundA novel non-canonical Wnt signature for prostate cancer aggressiveness
Sandsmark, E., Hansen, A. F., Selnæs, K. M., Bertilsson, H., Bofin, A. M., Wright, A. J., Viset, T., Richardsen, E. H., Drabløs, F., Bathen, T. F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14161 · Cited by 66
“Increased activation of the Wnt signaling pathway (WP) is associated with development, progression, and metastasis of many cancers [1].”
BackgroundLiu-Chittenden, Y., Jain, M., Gaskins, K., Wang, S., Merino, M. J., Kotian, S., Gara, S. K., Davis, S. R., Zhang, L., & Kebebew, E. (2017) · Oncogene · doi:10.1038/onc.2016.497 · Cited by 64
Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer
Kang, H. S., Kwon, H. Y., Kim, I. K., Ban, W. H., Kim, S. W., Kang, H. H., Yeo, C. D., & Lee, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-58906-7 · Cited by 67
New insights into the role of Runx1 in epithelial stem cell biology and pathology
Scheitz, C. J. F., & Tumbar, T. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24453 · Cited by 70
“Notably, Runx1 modulates Wnt signaling in normal skin biology and it is possible that this connection applies to cancer, since Wnt activation is a major path to cancer promotion [Polakis, 2012].”
BackgroundMultiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
Zhan, Y., & Fan, S. (2020) · Journal of Cancer · doi:10.7150/jca.39354 · Cited by 63
“Wnt signaling is detailedly discussed in many reviews [46].”
BackgroundShibayama, Y., Fujimori, T., Nguyen, G., Hirose, T., Totsune, K., Ichihara, A., Kitada, K., Nakano, D., Kobori, H., Kohno, M., et al. (2015) · Scientific Reports · doi:10.1038/srep08854 · Cited by 65
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.